Fundus Changes in the Microphthalmy Eyes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-05-31

Study Completion Date

2008-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal is to describe the fundamental aspects of fundoscopic eye in patients with microphthalmia

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Microphthalmos is a developmental ocular disorder defined as a small eyeball. The condition can be associated with abnormalities of anterior and posterior segments. The most common anterior characteristics include corneal opacities, angle-closure and a shallow anterior chamber and cataract. The main findings of posterior segment are uveal effusion, retinal folds, abnormalities of macular capillary vascularization, absence of foveal depression and peripheral retinoschisis. We performed on 3 patients with microphthalmos and their OCT features of posterior segment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eye Diseases, Hereditary

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

retina fold fovea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of microphthalmia

Exclusion Criteria

* Eyes larger than 18mm

Minimum Eligible Age

10 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fernando Jose De Novelli

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fernando J Novelli, Bsc

Role: PRINCIPAL_INVESTIGATOR

Hospital de Olhos Sadalla Amin Ghanem

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

sadalla1

Identifier Type: -

Identifier Source: org_study_id